Treatment and survival for non-Hodgkin's lymphoma: Influence of histological subtype, age, and other factors in a population-based study (1999-2001)

European Journal of Cancer

Volumn 42, Issue 16, 2006, Pages 2786-2793

  Cronin Fenton, Deirdre P ^a   Sharp, Linda ^a   Deady, Sandra ^a   Comber, Harry ^a  

^a NATIONAL CANCER REGISTRY IRELAND   (Ireland)

Author keywords

Chemotherapy; Non Hodgkin's lymphoma; Patterns of care; Radiotherapy; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; TISSUE TYPES;

AGED; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750068308     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.04.018     Document Type: Article

References (31)

1. Hartge P., and Devesa S.S. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res. 52 19 Suppl. (1992) 5566s-5569s
2. Sant M., Aareleid T., Berrino F., et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94-results and commentary. Ann Oncol 14 5 Suppl. 5 (2003) v61-v118
3. McLaughlin P. Progress and promise in the treatment of indolent lymphomas. Oncologist 7 3 (2002) 217-225
4. Fisher R., Miller T.P., and O'Connor O.A. Diffuse aggressive lymphoma. Hematology(Am Soc Hematol Educ Program) (2004) 221-236
5. Maartense E., Kluin-Nelemans H.C., le Cessie S., et al. Different age limits for elderly patients with indolent and aggressive non-Hodgkin's lymphoma and the role of relative survival with increasing age. Cancer 89 12 (2000) 2667-2676
6. Maartense E., Kramer M.H., le Cessie S., et al. Lack of prognostic significance of bcl-2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: results from a population-based non-Hodgkin's lymphoma registry. Leuk Lymphoma 45 1 (2004) 101-107
7. Janssen-Heijnen M.L., van Spronsen D.J., Lemmens V.E., et al. A population-based study of severity of comorbidity among patients with non-Hodgkin's lymphoma: prognostic impact independent of International Prognostic Index. Br J Haematol 129 5 (2005) 597-606
8. Scotland National Health Service. Hodgkin's disease and non-Hodgkin's lymphoma (2001), Scottish Executive, Edinburgh
9. www.nccn.org. Clinical Practise Guidelines in Oncology, National Cancer Comprehensive Network, 2005.
10. Winter J., Gascoyne R.D., and Van Besien K. Low-grade lymphoma. Hematology (Am Soc Hematol Educ Program) (2004) 203-220
11. Cronin D.P., Harlan L.C., Clegg L.X., et al. Patterns of care in a population-based random sample of patients diagnosed with non-hodgkin's lymphoma. Hematol Oncol 23 2 (2005) 73-81
12. Edwards B.K., Brown M.L., Wingo P.A., et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 97 19 (2005) 1407-1427
13. In: Percy C., Van Holten C., and Muir C. (Eds). International classification of diseases for oncology. 2nd ed. (1990), World Health Organisation, Geneva
14. Beahrs L.H., Henson D.E., Hutter R.V.P., and Kennedy B.J. Manual for staging of cancer. 4th ed. (1992), Lippincott Company, Chicago
15. Kramarova E, Stiller CA, Ferlay J, et al. International classification of childhood cancer 1996. In: IARC Technical Report. Lyon; 1996. p. 15.
16. Horning S.J., Negrin R.S., Hoppe R.T., et al. High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood 97 2 (2001) 404-409
17. Maloney D.G., Grillo-Lopez A., White C.A., et al. IDEC-C2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma. Blood 90 6 (1997) 2188-2195
18. Tsang R.W., Gospodarowicz M.K., and O'Sullivan B. Staging and management of localized non-Hodgkin's lymphomas: variations among experts in radiation oncology. Int J Radiat Oncol Biol Phys 52 3 (2002) 643-651
19. Coiffier B., Pfreundschuh M., Stahel R., Vose J., and Zinzani P.L. Effective immunochemotherapy for aggressive non-Hodgkin's lymphoma. Semin Oncol 31 1 Suppl. 2 (2004) 7-11
20. Clarke C.A., Glaser S.L., Dorfman R.F., et al. Expert review of non-Hodgkin's lymphomas in a population-based cancer registry: reliability of diagnosis and subtype classifications. Cancer Epidemiol Biomarkers Prev 13 1 (2004) 138-143
21. Turner J.J., Hughes A.M., Kricker A., et al. Use of the WHO lymphoma classification in a population-based epidemiological study. Ann Oncol 15 4 (2004) 631-637
22. de Rijke J.M., Schouten L.J., Schouten H.C., et al. Age-specific differences in the diagnostics and treatment of cancer patients aged 50 years and older in the province of Limburg, The Netherlands. Ann Oncol 7 7 (1996) 677-685
23. Lyman G.H., Dale D.C., Friedberg J., Crawford J., and Fisher R.I. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: a nationwide study. J Clin Oncol 22 21 (2004) 4302-4311
24. Dixon D.O., Neilan B., Jones S.E., et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience. J Clin Oncol 4 3 (1986) 295-305
25. van Spronsen D.J., Janssen-Heijnen M.L., Lemmens V.E., Peters W.G., and Coebergh J.W. Independent prognostic effect of co-morbidity in lymphoma patients: results of the population-based Eindhoven Cancer Registry. Eur J Cancer 41 7 (2005) 1051-1057
26. Yellen S.B., Cella D.F., and Leslie W.T. Age and clinical decision making in oncology patients. J Natl Cancer Inst 86 23 (1994) 1766-1770
27. Kravdal O. The impact of marital status on cancer survival. Soc Sci Med 52 3 (2001) 357-368
28. United Kingdom Office of National Statistics. Cancer Atlas of the United Kingdom and Ireland 1991-2000; 2005.
29. National Cancer Registry, Ireland. Cancer in Ireland 1994-2000. Cork; 2004.
30. Carli P.M., Coebergh J.W.W., Verdecchia A., et al. Variation in survival of adult patients with haematological malignancies in Europe Since 1978. Eur J Cancer 34 14 (1999) 2253-2263
31. Schetelig J., Fetscher S., Reichle A., et al. Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica 88 11 (2003) 1272-1278